This article is more than 5 years old. Information may no longer be current.

Interventional Spine receives FDA clearance for next generation fusion device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Interventional Spine Inc. recently announced FDA clearance of its next generation Opticage expandable interbody fusion device.

The new system is an enhanced version of the original Opticage system that was introduced in 2012, according to a press release. The next generation system reportedly features a streamlined profile compared with the previous implant, has an improved ability to deliver graft material after expansion and has improved ergonomics. In addition, the new design will have all of the features of the first-generation Opticage, including its adjustable and reversible height, graft contact and containment.

Interventional Spine Inc. plans to offer several common sizes of the new design in sterile packages. According to the release, the company plans to begin shipping the new Opticage in January.

Reference:

www.i-spineinc.com